Back to Search
Start Over
Site-directed mutagenesis in the P-domain of calreticulin transacylase identifies Lys-207 as the active site residue.
- Source :
-
3 Biotech [3 Biotech] 2021 Mar; Vol. 11 (3), pp. 113. Date of Electronic Publication: 2021 Feb 03. - Publication Year :
- 2021
-
Abstract
- In silico-docking studies from previous work have suggested that Lys-206 and lys-207 of calreticulin (CR) play a pivotal key role in its well-established transacetylation activity. To experimentally validate this prediction, we introduced three mutations at lysine residues of P-domain of CR: KâââA, P <superscript> mu t-1</superscript> (K -206, -209), P <superscript> mut -2</superscript> (K -206, -207) and P <superscript> mu t-3</superscript> (K -207, -209) and analyzed their immunoreactivity and acetylation potential. The clones of wild-type P-domain ( P <superscript> wt </superscript> ) and three mutated P-domain ( P <superscript> mut -1</superscript> , P <superscript> mu t-2</superscript> and P <superscript> mut -3</superscript> ) were expressed in pTrcHis C vector and the recombinant P <superscript> wt </superscript> , P <superscript> mut-1 </superscript> , P <superscript> mut-2 </superscript> and P <superscript> mut-3 </superscript> proteins were purified by Ni-NTA affinity chromatography. Screening of the transacylase activity (TAase) by the Glutathione S Transferase (GST) assay revealed that the TAase activity was associated with the P <superscript> wt </superscript> and P <superscript> mut-1 </superscript> while P <superscript> mut-2 </superscript> and P <superscript> mut-3 </superscript> did not show any activity. The immune-reactivity to anti-lysine antibody was also retained only by the P <superscript> mut-1 </superscript> in which the Lys-207 was intact. Retention of the TAase activity and immunoreactivity of P <superscript> mut -1</superscript> with mutations introduced at Lys-206, Lys-209, while its loss with a mutation at Lys-207 residue indicated that lysine-207 of P-domain constitutes the active site residue controlling TAase activity.<br />Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-021-02659-1.<br />Competing Interests: Conflicts of interestAll authors consent to this submission and declare no conflicts of interest.<br /> (© King Abdulaziz City for Science and Technology 2021.)
Details
- Language :
- English
- ISSN :
- 2190-572X
- Volume :
- 11
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- 3 Biotech
- Publication Type :
- Academic Journal
- Accession number :
- 33585151
- Full Text :
- https://doi.org/10.1007/s13205-021-02659-1